[1]
“GLYCEMIC CONTROL IN SUBJECTS WITH TYPE 2 DIABETES MELLITUS ON PREMIXED INSULIN REGIMEN TO BASAL-BOLUS INSULIN”, Int. Res. J. Pharm., vol. 13, no. 2, pp. 56–60, Aug. 2022, doi: 10.56802/zn0ypt34.